<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    12975222
   </pmid>
   <datecreated>
    <year>
     2003
    </year>
    <month>
     09
    </month>
    <day>
     16
    </day>
   </datecreated>
   <datecompleted>
    <year>
     2003
    </year>
    <month>
     10
    </month>
    <day>
     30
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2009
    </year>
    <month>
     11
    </month>
    <day>
     18
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Print">
      0820-3946
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       169
      </volume>
      <issue>
       6
      </issue>
      <pubdate>
       <year>
        2003
       </year>
       <month>
        Sep
       </month>
       <day>
        16
       </day>
      </pubdate>
     </journalissue>
     <title>
      CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
     </title>
     <isoabbreviation>
      CMAJ
     </isoabbreviation>
    </journal>
    <articletitle>
     Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.
    </articletitle>
    <pagination>
     <medlinepgn>
      557-64
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext label="BACKGROUND" nlmcategory="BACKGROUND">
      Cholinesterase inhibitors (ChEIs) are the only drugs marketed for the treatment of Alzheimer's disease. Despite numerous randomized controlled trials, the efficacy and safety of this group of medications has not been quantified. Our objective was to quantitatively summarize data on the efficacy and safety of ChEIs in Alzheimer's disease in a format useful to clinicians.
     </abstracttext>
     <abstracttext label="METHODS" nlmcategory="METHODS">
      We performed a meta-analysis of randomized, double-blind, placebo-controlled, parallel-group trials of currently marketed ChEIs (donepezil, rivastigmine and galantamine), used in therapeutic doses for at least 12 weeks, from which a cognitive outcome was reported. Studies were identified through 3 electronic databases searched to May 2002, pharmaceutical companies and journals. We extracted the proportions of subjects who responded, experienced adverse events, discontinued treatment for any reason or discontinued treatment because of adverse events.
     </abstracttext>
     <abstracttext label="RESULTS" nlmcategory="RESULTS">
      In the 16 identified trials that met the inclusion criteria, 5159 patients were treated with a ChEI and 2795 received a placebo. The pooled mean proportion of global responders to ChEI treatment in excess of that for placebo treatment was 9% (95% confidence interval [95% CI] 6%-12%). The rates of adverse events, dropout for any reason and dropout because of adverse events were also higher among the patients receiving ChEI treatment than among those receiving placebo, the excess proportions being 8% (95% CI 5%-11%), 8% (95% CI 5%-11%) and 7% (95% CI 3%-10%), respectively. The numbers needed to treat for 1 additional patient to benefit were 7 (95% CI 6-9) for stabilization or better, 12 (95% CI 9-16) for minimal improvement or better and 42 (95% CI 26-114) for marked improvement; the number needed to treat for 1 additional patient to experience an adverse event was 12 (95% CI 10-18).
     </abstracttext>
     <abstracttext label="INTERPRETATION" nlmcategory="CONCLUSIONS">
      Treatment with ChEIs results in a modest but significant therapeutic effect and modestly but significantly higher rates of adverse events and discontinuation of treatment. The numbers needed to treat to benefit 1 additional patient are small.
     </abstracttext>
    </abstract>
    <affiliation>
     Neuropharmacology Research Program, Department of Psychiatry, Sunnybrook &amp; Women's College Health Sciences Centre, Toronto, ON. Krista.Lanctot@sw.ca
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Lanct√¥t
      </lastname>
      <forename>
       Krista L
      </forename>
      <initials>
       KL
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Herrmann
      </lastname>
      <forename>
       Nathan
      </forename>
      <initials>
       N
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Yau
      </lastname>
      <forename>
       Kenneth K
      </forename>
      <initials>
       KK
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Khan
      </lastname>
      <forename>
       Lyla R
      </forename>
      <initials>
       LR
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Liu
      </lastname>
      <forename>
       Barbara A
      </forename>
      <initials>
       BA
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       LouLou
      </lastname>
      <forename>
       Maysoon M
      </forename>
      <initials>
       MM
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Einarson
      </lastname>
      <forename>
       Thomas R
      </forename>
      <initials>
       TR
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Clinical Trial
     </publicationtype>
     <publicationtype>
      Comparative Study
     </publicationtype>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Meta-Analysis
     </publicationtype>
     <publicationtype>
      Randomized Controlled Trial
     </publicationtype>
     <publicationtype>
      Review
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     Canada
    </country>
    <medlineta>
     CMAJ
    </medlineta>
    <nlmuniqueid>
     9711805
    </nlmuniqueid>
    <issnlinking>
     0820-3946
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Cholinesterase Inhibitors
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    AIM
   </citationsubset>
   <citationsubset>
    IM
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="Cites">
     <refsource>
      Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S22-32
     </refsource>
     <pmid version="1">
      9236949
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      BMJ. 1997 Sep 13;315(7109):629-34
     </refsource>
     <pmid version="1">
      9310563
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neurology. 1998 Jan;50(1):136-45
     </refsource>
     <pmid version="1">
      9443470
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Eur Neuropsychopharmacol. 1998 Feb;8(1):67-75
     </refsource>
     <pmid version="1">
      9452942
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Arch Intern Med. 1998 May 11;158(9):1021-31
     </refsource>
     <pmid version="1">
      9588436
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Hypertens. 1998 May;11(5):618-29
     </refsource>
     <pmid version="1">
      9633802
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neurochem Int. 1998 May-Jun;32(5-6):413-9
     </refsource>
     <pmid version="1">
      9676739
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 1998 Aug 22;352(9128):609-13
     </refsource>
     <pmid version="1">
      9746022
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      BMJ. 1998 Nov 7;317(7168):1309-12
     </refsource>
     <pmid version="1">
      9804726
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br J Clin Pharmacol. 1998 Nov;46 Suppl 1:1-6
     </refsource>
     <pmid version="1">
      9839758
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br J Clin Pharmacol. 1998 Nov;46 Suppl 1:7-12
     </refsource>
     <pmid version="1">
      9839759
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):137-47
     </refsource>
     <pmid version="1">
      10071091
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Can Fam Physician. 1999 Apr;45:917-9
     </refsource>
     <pmid version="1">
      10216789
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Dement Geriatr Cogn Disord. 1999 May-Jun;10(3):237-44
     </refsource>
     <pmid version="1">
      10325453
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Pharmacother. 1999 Apr;33(4):441-50
     </refsource>
     <pmid version="1">
      10332536
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Eur J Neurol. 1999 Jul;6(4):423-9
     </refsource>
     <pmid version="1">
      10362894
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Arch Neurol. 1999 Jun;56(6):735-7
     </refsource>
     <pmid version="1">
      10369315
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      CMAJ. 1999 Jun 15;160(12):1738-42
     </refsource>
     <pmid version="1">
      10410640
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      CMAJ. 1999 Jun 15;160(12 Suppl):S1-15
     </refsource>
     <pmid version="1">
      10410645
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      N Engl J Med. 1999 Nov 25;341(22):1670-9
     </refsource>
     <pmid version="1">
      10572156
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Arch Neurol. 2000 Jan;57(1):94-9
     </refsource>
     <pmid version="1">
      10634454
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Int J Geriatr Psychiatry. 2000 Mar;15(3):203-7
     </refsource>
     <pmid version="1">
      10713577
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Eur Neuropsychopharmacol. 2000 May;10(3):195-203
     </refsource>
     <pmid version="1">
      10793322
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Eur J Neurol. 2000 Mar;7(2):159-69
     </refsource>
     <pmid version="1">
      10809936
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neurology. 2000 Jun 27;54(12):2261-8
     </refsource>
     <pmid version="1">
      10881250
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neurology. 2000 Jun 27;54(12):2269-76
     </refsource>
     <pmid version="1">
      10881251
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neurology. 2000 Jul 12;55(1):66-73
     </refsource>
     <pmid version="1">
      10891908
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Clin Psychiatry. 2000 Jul;61(7):487-92
     </refsource>
     <pmid version="1">
      10937606
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):209-18
     </refsource>
     <pmid version="1">
      11001599
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Dement Geriatr Cogn Disord. 2000 Nov-Dec;11(6):299-313
     </refsource>
     <pmid version="1">
      11044775
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Eur Neurol. 2000;44(4):236-41
     </refsource>
     <pmid version="1">
      11096224
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      BMJ. 2000 Dec 9;321(7274):1445-9
     </refsource>
     <pmid version="1">
      11110737
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Drugs. 2000 Nov;60(5):1095-122
     </refsource>
     <pmid version="1">
      11129124
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Biol Psychiatry. 2001 Feb 1;49(3):289-99
     </refsource>
     <pmid version="1">
      11230880
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Can J Neurol Sci. 2001 Feb;28 Suppl 1:S3-16
     </refsource>
     <pmid version="1">
      11237309
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Dement Geriatr Cogn Disord. 2001 May-Jun;12(3):232-6
     </refsource>
     <pmid version="1">
      11244218
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Arch Neurol. 2001 Mar;58(3):417-22
     </refsource>
     <pmid version="1">
      11255445
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Arch Neurol. 2001 Mar;58(3):427-33
     </refsource>
     <pmid version="1">
      11255446
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Clin Neuropharmacol. 2001 Jan-Feb;24(1):31-42
     </refsource>
     <pmid version="1">
      11290880
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neurology. 2001 May 8;56(9):1154-66
     </refsource>
     <pmid version="1">
      11342679
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neurology. 2001 Aug 14;57(3):481-8
     </refsource>
     <pmid version="1">
      11502917
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neurology. 2001 Aug 14;57(3):489-95
     </refsource>
     <pmid version="1">
      11502918
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Eval Health Prof. 2001 Jun;24(2):152-64
     </refsource>
     <pmid version="1">
      11523384
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neurology. 2001 Aug 28;57(4):613-20
     </refsource>
     <pmid version="1">
      11524468
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Int J Geriatr Psychiatry. 2001 Sep;16(9):852-7
     </refsource>
     <pmid version="1">
      11571763
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Nucl Med. 2001 Oct;42(10):1441-5
     </refsource>
     <pmid version="1">
      11585854
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Int J Neuropsychopharmacol. 2001 Sep;4(3):223-30
     </refsource>
     <pmid version="1">
      11602028
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Neurol Neurosurg Psychiatry. 2001 Nov;71(5):589-95
     </refsource>
     <pmid version="1">
      11606667
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Eur Neurol. 2002;47(1):64-70
     </refsource>
     <pmid version="1">
      11803198
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Am Geriatr Soc. 2001 Dec;49(12):1590-9
     </refsource>
     <pmid version="1">
      11843990
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Int J Geriatr Psychiatry. 2002 Mar;17(3):270-8
     </refsource>
     <pmid version="1">
      11921156
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 2002 Apr 13;359(9314):1283-90
     </refsource>
     <pmid version="1">
      11965273
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Int J Clin Pract. 2002 Jul-Aug;56(6):441-6
     </refsource>
     <pmid version="1">
      12166542
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      JAMA. 2003 Jan 8;289(2):210-6
     </refsource>
     <pmid version="1">
      12517232
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Epidemiol Rev. 1992;14:154-76
     </refsource>
     <pmid version="1">
      1289110
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Psychopharmacol Bull. 1991;27(4):427-39
     </refsource>
     <pmid version="1">
      1813892
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Drug Intell Clin Pharm. 1988 Oct;22(10):813-24
     </refsource>
     <pmid version="1">
      3229352
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am Heart J. 1987 Feb;113(2 Pt 2):433-40
     </refsource>
     <pmid version="1">
      3544759
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Control Clin Trials. 1986 Sep;7(3):177-88
     </refsource>
     <pmid version="1">
      3802833
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Psychiatry. 1984 Nov;141(11):1356-64
     </refsource>
     <pmid version="1">
      6496779
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neurology. 1984 Jul;34(7):939-44
     </refsource>
     <pmid version="1">
      6610841
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Biometrics. 1994 Dec;50(4):1088-101
     </refsource>
     <pmid version="1">
      7786990
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Psychosom Res. 1994;38 Suppl 1:15-25
     </refsource>
     <pmid version="1">
      7799246
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      BMJ. 1995 Feb 18;310(6977):452-4
     </refsource>
     <pmid version="1">
      7873954
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neurology. 1994 Dec;44(12):2315-21
     </refsource>
     <pmid version="1">
      7991118
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      CMAJ. 1994 Mar 15;150(6):899-913
     </refsource>
     <pmid version="1">
      8131123
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann N Y Acad Sci. 1993 Sep 24;695:65-8
     </refsource>
     <pmid version="1">
      8239315
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Int J Clin Pharmacol Ther Toxicol. 1993 May;31(5):223-9
     </refsource>
     <pmid version="1">
      8314652
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Neurol. 1993 Sep;34(3):373-84
     </refsource>
     <pmid version="1">
      8363355
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neuropsychopharmacology. 1993 Jan;8(1):87-92
     </refsource>
     <pmid version="1">
      8424849
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Clin Pharmacokinet. 1995 Sep;29(3):192-209
     </refsource>
     <pmid version="1">
      8521680
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Life Sci. 1996;58(15):1201-7
     </refsource>
     <pmid version="1">
      8614273
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Control Clin Trials. 1996 Feb;17(1):1-12
     </refsource>
     <pmid version="1">
      8721797
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Dementia. 1996 Nov-Dec;7(6):293-303
     </refsource>
     <pmid version="1">
      8915035
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Prog Brain Res. 1996;109:299-309
     </refsource>
     <pmid version="1">
      9009718
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      BMJ. 1999 Mar 6;318(7184):633-8
     </refsource>
     <pmid version="1">
      10066203
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      CMAJ. 2004 Apr 27;170(9):1372; author reply 1372-4
     </refsource>
     <pmid version="1">
      15111454
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      CMAJ. 2004 Apr 27;170(9):1371-2; author reply 1372-4
     </refsource>
     <pmid version="1">
      15111452
     </pmid>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Alzheimer Disease
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug therapy
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Cholinesterase Inhibitors
     </descriptorname>
     <qualifiername majortopicyn="N">
      administration &amp; dosage
     </qualifiername>
     <qualifiername majortopicyn="Y">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Dose-Response Relationship, Drug
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Double-Blind Method
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Time Factors
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Treatment Outcome
     </descriptorname>
    </meshheading>
   </meshheadinglist>
   <numberofreferences>
    90
   </numberofreferences>
   <otherid source="NLM">
    PMC191283
   </otherid>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      2003
     </year>
     <month>
      9
     </month>
     <day>
      17
     </day>
     <hour>
      5
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      2003
     </year>
     <month>
      10
     </month>
     <day>
      31
     </day>
     <hour>
      5
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      2003
     </year>
     <month>
      9
     </month>
     <day>
      17
     </day>
     <hour>
      5
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     12975222
    </articleid>
    <articleid idtype="pmc">
     PMC191283
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

